Statistics for Dyne Therapeutics (id:7925 DYN)
Valuation metrics
Market cap
3.05B
Enterprise value
2.32B
Trailing P/E (ttm)
-7.52
Forward P/E
-9.49
PEG ratio
-9.49
Price/Sales (ttm)
Price/Book (mrq)
4.33
Enterprise Value/Revenue
Enterprise Value/EBITDA
-7.42
Overview
Shares outstanding
101.77M
Float
74.77M
Shares short
9.94M
% Held by insiders
0.00%
% Held by institutions
1.12%
Average volume (10 days)
1.29M
Average volume (90 days)
Price summary
52-Week low
10.12
52-Week high
47.45
52-Week change
64.10%
Beta
1.10
50-Day moving average
32.42
200-Day moving average
32.25
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-40.35%
Return on equity
-68.68%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-312,844,000.00
Net income to common (ttm)
-294,513,984.00
Diluted EPS (ttm)
-3.58
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
723.67M
Total cash per share (mrq)
7.11
Total debt (mrq)
24.86M
Total Debt/Equity (mrq)
3.52
Current ratio (mrq)
1.70K%
Book value per share (mrq)
6.93
Cash flow
Cash flow statement
-243,040,000.00
Levered free cash flow (LFCF)
-144,041,248.00